Literature DB >> 20799311

α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPB.

Koen Steert1, Maya Berg, Jeremy C Mottram, Gareth D Westrop, Graham H Coombs, Paul Cos, Louis Maes, Jurgen Joossens, Pieter Van der Veken, Achiel Haemers, Koen Augustyns.   

Abstract

Cysteine proteases of the papain superfamily are present in nearly all eukaryotes and also play pivotal roles in the biology of parasites. Inhibition of cysteine proteases is emerging as an important strategy to combat parasitic diseases such as sleeping sickness, Chagas disease, and leishmaniasis. Inspired by the in vivo antiparasitic activity of the vinylsulfone-based cysteine protease inhibitors, a series of α-ketoheterocycles were developed as reversible inhibitors of a recombinant L. mexicana cysteine protease, CPB2.8. Three isoxazoles and especially one oxadiazole compound are potent reversible inhibitors of CPB2.8; however, in vitro whole-organism screening against a panel of protozoan parasites did not fully correlate with the observed inhibition of the cysteine protease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20799311      PMCID: PMC3245848          DOI: 10.1002/cmdc.201000265

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  37 in total

1.  Design and synthesis of dipeptide nitriles as reversible and potent Cathepsin S inhibitors.

Authors:  Yancey D Ward; David S Thomson; Leah L Frye; Charles L Cywin; Tina Morwick; Michel J Emmanuel; Renée Zindell; Daniel McNeil; Younes Bekkali; Marc Girardot; Matt Hrapchak; Molly DeTuri; Kathy Crane; Della White; Susan Pav; Yong Wang; Ming-Hong Hao; Christine A Grygon; Mark E Labadia; Dorothy M Freeman; Walter Davidson; Jerry L Hopkins; Maryanne L Brown; Denice M Spero; Marc Giradot
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

Review 2.  Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design.

Authors:  Fabien Lecaille; Jadwiga Kaleta; Dieter Brömme
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

3.  Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.

Authors:  Lily Huang; Linda S Brinen; Jonathan A Ellman
Journal:  Bioorg Med Chem       Date:  2003-01-02       Impact factor: 3.641

Review 4.  Cysteine proteases of parasitic organisms.

Authors:  M Sajid; J H McKerrow
Journal:  Mol Biochem Parasitol       Date:  2002-03       Impact factor: 1.759

5.  The stage-regulated expression of Leishmania mexicana CPB cysteine proteases is mediated by an intercistronic sequence element.

Authors:  D R Brooks; H Denise; G D Westrop; G H Coombs; J C Mottram
Journal:  J Biol Chem       Date:  2001-10-09       Impact factor: 5.157

6.  Concise and stereocontrolled synthesis of pseudo-C2-symmetric diamino alcohols and triamines for use in HIV protease inhibitors.

Authors:  Luca Bernardi; Bianca F Bonini; Gabriella Dessole; Mariafrancesca Fochi; Mauro Comes-Franchini; Silvia Gavioli; Alfredo Ricci; Greta Varchi
Journal:  J Org Chem       Date:  2003-02-21       Impact factor: 4.354

7.  Analysis of the roles of cysteine proteinases of Leishmania mexicana in the host-parasite interaction.

Authors:  M J Frame; J C Mottram; G H Coombs
Journal:  Parasitology       Date:  2000-10       Impact factor: 3.234

8.  Design and evaluation of Trypanosoma brucei metacaspase inhibitors.

Authors:  Maya Berg; Pieter Van der Veken; Jurgen Joossens; Venkatraj Muthusamy; Matthias Breugelmans; Catherine X Moss; Jana Rudolf; Paul Cos; Graham H Coombs; Louis Maes; Achiel Haemers; Jeremy C Mottram; Koen Augustyns
Journal:  Bioorg Med Chem Lett       Date:  2010-01-25       Impact factor: 2.823

9.  The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses.

Authors:  Kevin G J Pollock; Katherine S McNeil; Jeremy C Mottram; Russell E Lyons; James M Brewer; Phillip Scott; Graham H Coombs; James Alexander
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

10.  Expression of multiple CPB genes encoding cysteine proteases is required for Leishmania mexicana virulence in vivo.

Authors:  Hubert Denise; Kathryn McNeil; Darren R Brooks; James Alexander; Graham H Coombs; Jeremy C Mottram
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more
  6 in total

Review 1.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

2.  PCI-24781 down-regulates EZH2 expression and then promotes glioma apoptosis by suppressing the PIK3K/Akt/mTOR pathway.

Authors:  Wei Zhang; Shengqing Lv; Jun Liu; Zhenle Zang; Junyi Yin; Ning An; Hui Yang; Yechun Song
Journal:  Genet Mol Biol       Date:  2014-10-21       Impact factor: 1.771

Review 3.  Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host.

Authors:  Vitor Sueth-Santiago; Debora Decote-Ricardo; Alexandre Morrot; Celio Geraldo Freire-de-Lima; Marco Edilson Freire Lima
Journal:  World J Biol Chem       Date:  2017-02-26

4.  Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB.

Authors:  Jörg Schröder; Sandra Noack; Richard J Marhöfer; Jeremy C Mottram; Graham H Coombs; Paul M Selzer
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

5.  Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II-Design, Synthesis, and Evaluation.

Authors:  Michal Maryška; Lucie Svobodová; Wim Dehaen; Martina Hrabinová; Michaela Rumlová; Ondřej Soukup; Martin Kuchař
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-10

6.  Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.

Authors:  Leandro da Costa Clementino; Guilherme Felipe Santos Fernandes; Igor Muccilo Prokopczyk; Wilquer Castro Laurindo; Danyelle Toyama; Bruno Pereira Motta; Amanda Martins Baviera; Flávio Henrique-Silva; Jean Leandro Dos Santos; Marcia A S Graminha
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.